Asia Deal Watch: Strides Obtains 18 US ANDAs From Pharmaceutics
Deal news from Strides Pharma, Pharmaceutics Intl., Cipla, Wanbury, AstraZeneca, Syntekabio, Arctoris, Mundipharma, Samsung Bioepis…
You may also be interested in...
Financially stretched Wockhardt sells select branded generic business to Dr Reddy’s for $260m, bringing the curtains down on a much anticipated transaction.
Stada has added to its consumer healthcare business in the Philippines by acquiring the Fern C range of vitamin C food supplements.
Japan’s Towa has completed its €329m deal for the Pensa Investments generics business of Spain’s Esteve.